IBB vs XLB

iShares Biotechnology ETF vs Materials Select Sector SPDR

Quick take
  • XLB has the lower expense ratio at 0.08% vs 0.44% for IBB.
  • XLB pays a higher dividend yield (1.70%).

Side-by-side metrics

MetricIBBXLB
Expense ratio
Annual fee. Lower is better.
0.44%0.08%
Dividend yield
Trailing 12-month yield.
0.23%1.70%
AUM
Assets under management — bigger funds are typically more liquid.
$7.95B$7.31B
YTD return
3.10%16.07%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.740.95
P/E ratio
23.7225.96
Last price
$170.10$51.40
Inception
Issuer
iSharesState Street

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

XLB top holdings

Top holdings · XLB
LINLinde PLC14.14%
NEMNewmont Corp7.33%
NUENucor Corp5.68%
FCXFreeport-McMoRan Inc5.02%
CRHCRH PLC4.93%
VMCVulcan Materials Co4.85%
APDAir Products and Chemicals Inc4.68%
MLMMartin Marietta Materials Inc4.49%
SHWSherwin-Williams Co4.48%
CTVACorteva Inc4.46%
Sector breakdown · XLB
Consumer Cyclical12.4%
Basic Materials87.6%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About XLB

XLB (Materials Select Sector SPDR) is S&P 500 materials sector. Managed by State Street, the fund carries $7.3B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.70%. Its largest holding is Linde PLC (LIN), which represents 14.1% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 12.4%.